Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172752 · ClinicalTrials.gov registry record · NA
A University-Community Partnership to Reduce Exposure to Disinfection Byproducts In Appalachia
A NA study of Disinfection By-products, sponsored by Anna Hoover.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05172752: Recruiting NA study of Disinfection By-products, sponsored by Anna Hoover.
NCT05172752 is a NA study of Disinfection By-products that is actively recruiting participants, run by Anna Hoover. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05172752, a NA study of Disinfection By-products, is actively recruiting participants, sponsored by Anna Hoover.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Appalachian Kentuckians in Martin and Letcher Counties are grappling with a health-threatening drinking water crisis arising from exposures to disinfection by-products (DBPs). DBPs include trihalomethanes (THMs), haloacetic acids (HAAs), chlorate, and other compounds that have been associated with a variety of adverse health effects, including increased risk of bladder cancer and cardiovascular birth defects. This study implements a multi-stakeholder, multi-method approach to improve understanding of, characterize spatial and temporal variations in, and reduce exposure to DBPs in these Appalachian Kentucky counties.
Primary Outcome
Study participants will complete pre-/post-surveys of disinfection byproducts-related knowledge. Participants will answer 21 questions with multiple choice or fill in the blank response options that will be assessed for correctness/completeness.
Conditions Studied
Interventions
- OTHER Citizen Scientist Training Program
- OTHER Stakeholder Consultation Core Program
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-02-25 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05172752 shows while recruiting
NCT05172752 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Disinfection By-products appearing as the primary indexed condition, and to 2 interventions - of which Citizen Scientist Training Program is the first listed.
NCT05172752 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05172752 about?
NCT05172752 is a clinical study titled "A University-Community Partnership to Reduce Exposure to Disinfection Byproducts In Appalachia". Appalachian Kentuckians in Martin and Letcher Counties are grappling with a health-threatening drinking water crisis arising from exposures to disinfection by-products (DBPs). DBPs include trihalomethanes (THMs), haloacetic acids (HAAs), chlorate, and other compounds that have been associated with a...
What is the current status of trial NCT05172752?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-02-25. Estimated completion is 2026-07.
What conditions does trial NCT05172752 study?
This clinical trial studies the following conditions: Disinfection By-products.
What interventions are being tested in trial NCT05172752?
The interventions under investigation include: Citizen Scientist Training Program (OTHER), Stakeholder Consultation Core Program (OTHER).
Who is sponsoring clinical trial NCT05172752?
This trial is sponsored by Anna Hoover, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05172752 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05172752's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI